Skip to content. | Skip to navigation

Personal tools

  • Le CIRI sur Linkedin
Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1

Secondary managing bodies

logo ENSL logo ucb1

You are here: Home / Teams / Vocanson M - IEA / Publications

Publications

 PUBLICATIONS

Scientific articles

Original Publications with a member of the team as lead author (1st or last author (and co-first and co-last))

  1. Braun C, Badiou C, Guironnet-Paquet A, Iwata M, Lenief V, Mosnier A, Beauclair C, Renucci E, Bouschon P, Cuzin R, Briend Y, Patra VK, Patot S, Scharschmidt TC, van Wamel W, Lemmens N, Nakajima S, Vandenesh F, Nicolas JF, Lina G, Nosbaum A, Vocanson M. Staphylococcus aureus-specific skin resident memory T cells protect against bacteria colonization but exacerbate atopic dermatitis-like flares in mice. J Allergy Clin Immunol. 2024. 154(2):355-374. 
  2. Lefevre MA, Nosbaum A, Mosnier A, Lenief V, Salque S, Pichot M, Maheux L, Bertolotti L, Hacard F, Graveriau C, Zukervar P, Breton Guitarian AL, Boisleve F, Elbaz M, Nicolas JF, Vocanson M. Gene profiling in active dermatitis lesions strengthens the diagnosis of allergic contact dermatitis. J Am Acad Dermatol. 2024. 90(5):953-962.
  3. Ono E, Lenief V, Lefevre MA, Cuzin R, Guironnet-Paquet A, Mosnier A, Nosbaum A, Nicolas JF, Vocanson M. Topical corticosteroids inhibit allergic skin inflammation but are ineffective in impeding the formation and expansion of resident memory T cells. Allergy. 2024. 79(1):52-64.
  4. Morot J, Del Duca E, Chastagner M, Fernandes M, Estrada Y, Lefevre MA, Kanitakis J, Harou O, Jullien D, Nicolas JF, Krueger JG, Vocanson M*, Guttman-Yassky E*, Villani AP*. Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic Cellulitis. JAMA Dermatol. 2023. 159(8):820-829. *Equal contributors.
  5. Laoubi L, Lacoffrette M, Valsesia S, Lenief V, Guironnet-Paquet A, Mosnier A, Dubois, G, Cartier A, Monti L, Marvel J, Espinosa E, Malissen B, Henri S, Mondoulet L, Sampson, HA, Nosbaum A, Nicolas JF, Dioszeghy V* and Vocanson M*. Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic cell subsets. J Allergy Clin Immunol. 2022. 150(5):1194-1208. *Equal contributors.
  6. Ljungberg Silic L*, Lefevre MA*, Bergendorff O, De Bernard S, Nourikyan J, Buffat L, Nosbaum A, Bruze M, Nicolas JF, Svedman C, Vocanson M.  Gene profiling reveals a contact allergy signature in most positive Amerchol L-101 patch-test reactions. Contact Dermatitis. 2022. 87(1):40-52.
  7. Lefevre MA*, Nosbaum A*, Rozières A, Lenief V, Mosnier A, Cortial A, Prieux M, De Bernard S, Nourikyan J, Jouve PE, Buffat L, Hacard F, Ferrier-Lebouedec MC, Pralong P, Dzviga C, Herman A, Baeck M, Nicolas JF, Vocanson M. Unique molecular signatures typify skin inflammation induced by chemical allergens and irritants. Allergy. 2021. 76(12):3697-3712.
  8. Villani AP*, Rozieres A*, Bensaid B, Eriksson KK, Mosnier A, Albert F, Mutez V, Brassard O, Baysal T, Tardieu M, Allatif O, Fusil F, Andrieu T, Jullien D, Dubois V, Giannoli C, Gruffat H, Pallardy M, Cosset FL, Nosbaum A, Kanagawa O, Maryanski JL, Yerly D, Nicolas JF*, Vocanson M*. Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis. Sci Adv. 2021. 7(12):eabe0013.
  9. Hequet O, Nosbaum A, Guironnet-Paquet A, Blasco E, Nicolas-Virelizier E, Griffith T, Rigal D, Cognasse F, Nicolas JF and Vocanson M. CD8+ T cells mediate ultraviolet A-induced immunomodulation in a murine model of extracorporeal photochemotherapy. Eur J immunol. 2020. 50(5):725-735.   
  10. Gamradt P*, Laoubi L*, Nosbaum A, Mutez V, Lenief V, Grande S, Redoulès D, Schmidt AM, Nicolas JF, Vocanson M. Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy. J Allergy Clin Immunol. 2019. 143(6):2147-2157. *Equal contributors.
  11. Hequet O, Poutrel S, Connes P, Revesz D, Chelghoum Y, Kebaili K, Cannas G, Gauthier A, Guironnet-Paquet A, Vocanson M, Nicolas JF, Renoux C, Raba M, Cognasse F, Bertrand Y, Hot A, Joly P. Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients. Transfusion. 2019 Feb 12. doi: 10.1111/trf.15188.
  12. Goujon C, Viguier M, Staumont-Sallé D, Bernier C, Guillet G, Lahfa M, Ferrier Le Bouedec MC, Cambazard F, Bottigioli D, Grande S, Dahel K, Bérard F, Rabilloud M, Mercier C, Nicolas JF. Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial. J Allergy Clin Immunol Pract. 2018. 6(2):562-569.
  13. Ventre E, Rozières A, Lenief V, Albert F, Rossio P, Laoubi L, Dombrowicz D, Staels B, Ulmann L, Julia V, Vial E, Jomard A, Hacini-Rachinel F, Nicolas JF, Vocanson M. Ivermectin improves allergic skin inflammation through direct inhibition of T cell activation. Allergy. 2017, 72(8):1212-1221.
  14. Bernard M, Guiraud B, Nicolas JF, Bessou-Touya S, Duplan H, Rozières A, Goujon C, Galliano MF*, Vocanson M*. IL-1beta promotes atopic dermatitis phenotype in reconstructed human epidermis. J Pathol. 2017, 242(2):234-245. *Equal contributors.
  15. Skowron F, Bensaid B, Balme B, Depaepe L, Kanitakis J, Nosbaum A, Maucort-Boulch D, Bérard F, D'Incan M, Kardaun SH, Nicolas JF. Comparative histological analysis of drug-induced maculopapular exanthema and DRESS. J Eur Acad Dermatol Venereol. 2016. 30(12):2085-2090.
  16. Cortial M, Rozières A, Baeck M, De Montjoye L, Grande S, Briançon S, Nicolas JF, Vocanson M. Encapsulation of hydrophobic allergens into nanoparticles improves the in vitro immunological diagnosis of allergic contact dermatitis. Nanomedicine. 2015, 11(4):1029-33.
  17. Vocanson M*, Achachi A*, Bastien P, Péguet-Navarro J, Grande S, Goujon C, Castiel-Higounenc I, Breton L, Nicolas JF * and Gueniche A*. UV radiation induces the epidermal recruitment of inflammatory dendritic cells that compensate for the depletion of Langerhans cells in human skin. J Invest Dermatol. 2015,135(8):2058-67.  *Equal contributors.
  18. Skowron F, Bensaid B, Balme B, Depaepe L, Kanitakis J, Nosbaum A, Maucort-Boulch D, Bérard F, D'Incan M, Kardaun SH, Nicolas JF. Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases. J Eur Acad Dermatol Venereol. 2015, 29(11):2199-205.
  19. Ben-Said B, Arnaud-Butel S, Rozières A, Rodet K, Bérard F, Nicolas JF, Nosbaum A. Allergic delayed drug hypersensitivity is more frequently diagnosed in drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome than in exanthema induced by beta-lactam antibiotics. J Dermatol Sci. 2015, 80(1):71-4.

 

Original Publications. Collaborative articles (participation as non-lead author)

  1. Patra V, Woltsche N, Cerpes U, Bokanovic D, Repelnig M, Joshi A, Perchthaler I, Fischl M, Vocanson M, Bordag N, Durdevic M, Woltsche J, Quehenberger F, Legat F, Wedrich A, Horwath-Winter J, Wolf P. Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab-Associated Conjunctivitis in Patients with Atopic Dermatitis. Ophthalmol Sci. 2023. 29;4(1):100340.
  2. Galbiati V, Lefevre MA, Maddalon A, Vocanson M, Iulini M, Marinovich M, Corsini E. Role of miR-24-3p and miR-146a-5p in dendritic cells' maturation process induced by contact sensitizers. Arch Toxicol. 2023. 97(8):2183-2191.
  3. Patra V, Bordag N, Clement Y, Köfeler H, Nicolas JF, Vocanson M, Ayciriex S, Wolf P. Ultraviolet exposure regulates skin metabolome based on the microbiome. Sci Rep. 2023. 13(1):7207.
  4. Patra V, Strobl J, Atzmüller D, Reininger B, Kleissl L, Gruber-Wackernagel A, Nicolas JF, Stary G, Vocanson M, Wolf P. Accumulation of Cytotoxic Skin Resident Memory T Cells and Increased Expression of IL-15 in Lesional Skin of Polymorphic Light Eruption. Front Med (Lausanne). 2022. 9:908047.
  5. Chedid C, Andrieu T, Kokhreidze E, Tukvadze N, Biswas S, Ather MF, Uddin MKM, Banu S, De Maio F, Delogu G, Endtz H, Goletti D, Vocanson M, Dumitrescu O, Hoffmann J, Ader F. In-Depth Immunophenotyping With Mass Cytometry During TB Treatment Reveals New T-Cell Subsets Associated With Culture Conversion. Front Immunol. 2022. 13:853572.
  6. Lalle G, Lautraite R, Voisin A, Twardowski J, Stéphan P, Perrin-Niquet M, Igalouzene R, Soudja SM, Marie JC, Vocanson M, De Silva N, Klein U, Ghosh S, Grinberg-Bleyer Y. A T cell-intrinsic function for NF-κB RelB in experimental autoimmune encephalomyelitis. Sci Rep. 2021. 11(1):19674.
  7. Kalekar LA, Cohen JN, Prevel N, Sandoval PM, Mathur AN, Moreau JM, Lowe MM, Nosbaum A, Wolters PJ, Haemel A, Boin F, Rosenblum MD. Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses. Sci Immunol. 2019. 4(39):eaaw2910.

 

Reviews

Reviews with a member of the team as lead author (1st or last).

  1. Cadot R, Gery P, Lenief V, Nicolas JF, Vocanson M, Tauber M. Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology. Allergy. 2025;80(1):47-62. doi:10.1111/all.16316
  2. Braun C, Coutier L, Bégin P, Nosbaum A. Skin-centered strategies in food allergy prevention. Pediatr Allergy Immunol. 2024. 35(5):e14130.
  3. Guillon C, Meziani M, Abdelli S, Sigaudo Roussel D, Bonod C, Nosbaum A. The aryl hydrocarbon receptor pathway plays a central role in the cutaneous response to pollutants. Eur J Dermatol. 2022; 32(3):305-311.
  4. Chastagner M, Shourik J, Jachiet M, Battistella M, Lefevre G, Gibier JB, Aubert H, Musquer M, Descamps V, Deschamps L, Chosidow O, Ortonne N, Groh M, Bernier M, Jullien D, Chasset F, Staumont-Salle D, Bouaziz JD, Kanitakis J, Villani AP. Treatment of Eosinophilic Annular Erythema: Retrospective multicenter study and literature review. Ann Dermatol Venereol. 2022. 149(2):123-127.
  5. Braun C, Patra V, Lina G, Nicolas JF, Vocanson M, Nosbaum A. The role of skin dysbiosis in atopic dermatitis. Eur J Dermatol. 2022 Jul 1;32(4):439-444.
  6. Scheinman PL, Vocanson M, Thyssen JP, Johansen JD, Nixon RL, Dear K, Botto NC, Morot J, Goldminz AM. Contact dermatitis. Nat Rev Dis Primers. 2021. 7(1):38.
  7. Nosbaum A, Dahel K, Goujon C, Nicolas JF, Mengeaud V, Vocanson M. Psoriasis is a disease of the entire skin: non-lesional skin displays a prepsoriasis phenotype. Eur J Dermatol. 2021 Apr 1;31(2):143-154.
  8. Nosbaum A, Nicolas JF, Lustig S, Vocanson M. When Joints Fail: Identifying the Allergen Helps. J Allergy Clin Immunol Pract. 2021 Aug;9(8):3118-3119.
  9. Lefevre MA, Nosbaum A. Dermpath and Clinic: How to manage adverse reactions to biological agents. Eur J Dermatol. 2021. 31(3):426-427.
  10. Boisson C, Rab MAE, Nader E, Renoux C, Kanne C, Bos J, van Oirschot BA, Joly P, Fort R, Gauthier A, Stauffer E, Poutrel S, Kebaili K, Cannas G, Garnier N, Renard C, Hequet O, Hot A, Bertrand Y, van Wijk R, Sheehan VA, van Beers EJ, Connes P. Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease. Cells. 2021 Apr 5;10(4):811.
  11. Lefevre MA, Vocanson M, Nosbaum A. Role of tissue-resident memory T cells in the pathophysiology of allergic contact dermatitis. Curr Opin Allergy Clin Immunol. 2021 Aug 1;21(4):355-360.
  12. Villani AP. Le choix thérapeutique : médicaments du psoriasis et grossesse avant, pendant et après la grossesse. Eur J Dermatol. 2020. 30(S1):8-13.
  13. Braun C, Vocanson M, Nicolas JF, Nosbaum A. Physiopathologie de la dermatite atopique et des autres maladies atopiques : une approche globale est-elle possible ?: Pathophysiology of atopic dermatitis and other atopic diseases: is a global approach possible? Ann Dermatol Venereol. 2020 Nov;147(11S1):11S4-11S11.
  14. Vocanson M, Naisbitt D, Nicolas JF. Current perspective of the etiopathogenesis of delayed-type, and T cell-mediated drug related skin diseases. J Allergy Clin Immunol. 2020. 145(4):1142-1144.
  15. Martin L, Nicolas JF. [Regulatory T cells control hair growth and prevent the development of alopecia areata]. Med Sci (Paris). 2020. 36(10):941-943.
  16. Khandzian M, Hacard F, Braire-Bourrel M, Jaulent C, Bérard F, Nicolas JF, Nosbaum A. NSAID urticaria: Similar management to acute urticaria. Rev Med Interne. 2019. 40(3):166-172.
  17. Goujon C, Nicolas JF, Nosbaum A. Methotrexate in atopic eczema. Comments to: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol.  2019. 33(4):e154-e155.
  18. Villani AP, Gamradt P, Nosbaum A, Laoubi L, Jullien D, Nicolas JF, Vocanson M. Immune-mediated skin diseases induced by chemicals and drugs. Curr Opin Toxicol. 2018, 10 :111-116.
  19. Patra V, Laoubi L, Nicolas JF, Vocanson M, Wolf P. A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells. Front Med (Lausanne). 2018. 30;5:166.
  20. Vocanson M, Mutez V, Esser PR, Cluzel M, Nosbaum A, Martin SF, Nicolas JF. Contact hypersensitivity: T-cell based assay. Curr Opin Toxicol. 2017, 5:39-45.
  21. Hoelt P, Confavreux C, Jullien D, Villani AP. Management of psoriatic arthritis among cutaneous psoriasis patients: from pathogenesis to therapy. G Ital Dermatol Venereol. 2017. 152(5):458-473.
  22. Bensaïd B, Valeyrie-Allanore L, Lebrun-Vignes B, Nicolas JF. Drug induced exanthema and severe cutaneous reactions.  Rev Prat. 2015. 65(7):981-5.
  23. Villani A, Demoly P, Nicolas JF. Drug hypersensitivity: definitions and mechanisms. Rev Prat. 2015. 65(7):969-71.
  24. Hacard F, Nosbaum A, Huynh VA, Nicolas JF, Bérard F. Diversity of cutaneous bacteria decreases inflammation. Ann Dermatol Venereol. 2015. 142 Suppl 1:S13-7.
  25. Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, Beylot-Barry M, Misery L, Joly P, Le Maitre M, Aractingi S, Aubin F, Cantagrel A, Ortonne JP, Jullien D. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis. J Am Acad Dermatol. 2015. 73(2):242-8.
  26. Jullien D, Prinz JC, Nestle FO. Immunogenicity of biotherapy used in psoriasis: the science behind the scenes. J Invest Dermatol. 2015. 135(1):31-38.

 

Reviews. Collaborative articles (participation as non-lead author).

  1. Hama N, Aoki S, Chen CB, Hasegawa A, Ogawa Y, Vocanson M, Asada H, Chu CY, Lan CE, Dodiuk-Gad RP, Fujiyama T, Hsieh TS, Ito K, Jerschow E, Mizukawa Y, Nakajima S, Nakamura K, Nicolas JF, Satoh TK, Shiohara T, Takahashi H, Tohyama M, Ueda T, Ura K, Watanabe H, Yamaguchi Y, Nordmann TM, Chung WH, Naisbitt D, Pincelli C, Pichler WJ, French LE, Phillips E, Abe R. Recent progress of Stevens-Johnson syndrome/toxic epidermal necrolysis: Diagnosis criteria, pathogenesis and therapy. Br J Dermatol. 2024 Aug 14:ljae321.
  2. Magnan A, Nicolas JF, Caimmi D, Vocanson M, Haddad T, Colas L, Scurati S, Mascarell L, Shamji MH. Deciphering Differential Behavior of Immune Responses as the Foundation for Precision Dosing in Allergen Immunotherapy. J Pers Med. 2023. 13(2):324.
  3. Joshi AA, Vocanson M, Nicolas JF, Wolf P, Patra V. Microbial derived antimicrobial peptides as potential therapeutics in atopic dermatitis. Front Immunol. 2023. 14:1125635.
  4. Benhadou F, Villani AP, Guillem P. Factors Determining Affected Sites in Hidradenitis Suppurativa. Dermatology. 2021. 1:1-3.
  5. Alberto C, Osdoit S, Villani AP, Bellec L, Belmonte O, Schrenzel J, Bagny K, Badell E, Brisse S, Toubiana J. Cutaneous ulcers revealing diphtheria: A re-emerging disease imported from Indian Ocean countries? Ann Dermatol Venereol. 2021. 148(1):34-39.
  6. Lalevée S, Contassot E, Ortonne N, Gaudin O, Ben Said B, Vocanson M, De Prost N, Wolkenstein P, Hue S, Ingen-Housz-Oro S. [Advances in understanding of the pathophysiology of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis)]. Ann Dermatol Venereol. 2020 Jun-Jul;147(6-7):475-481
  7. Jelti L, Prost-Squarcioni C, Ingen-Housz-Oro S, Caux F, Bernard P, Bedane C, Alexandre M, Dereure O, Quereux G, Le Bidre E, Plée J, Picard-Dahan C, Le Roux-Villet C, Duvert-Lehembre S, Richard MA, Delaporte E, Debarbieux S, Jullien D, D'Incan M, Konstantinou MP, Bouaziz JD, Tancrède-Bohin E, Doutre MS, Bourgault Villada I, Cordel N, Sassolas B, Viguier MA, Mellottée B, Jouen F, Hebert V, Joly P; Centre de référence des maladies bulleuses auto-immunes (MALIBUL); Groupe Bulles de la SFD et la Filière des maladies rares dermatologiques (FIMARAD). Update of the French recommendations for the management of pemphigus. Ann Dermatol Venereol. 2019 Mar 28. pii: S0151-9638(19)30059-6.
  8. Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP, Egeberg A. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019. 80(1):251-265.e19.

Clinical articles

Clinical articles with a member of the team as lead author (ancillary studies, clinical cases, clinical trials) (1st or last).

  1. Fargeas M, Fauvernier M, Tauber M, Seneschal J, Verdu V, Bourrel Bouttaz M, Hacard F, Darrigade AS, Nosbaum A; Eczema Foundation; French Group on Therapeutic Education in Dermatology (GET). Effect of Therapeutic Patient Education in Adults with Atopic Dermatitis: Analysis of Efficacy and Treatment Needs. Acta Derm Venereol. 2024 Dec 12;104:adv41184.
  2. Reynaud V, Chircop I, Hacard F, Nicolas JF, Berard F, Mosnier A, Vocanson M, Nosbaum A. Unusual dermatitis in response to a transcutaneous electrical nerve stimulation device. Eur J Dermatol. 2024 Jun 1;34(3):341-342.
  3. Chastagner M, Guillem P, Jullien D, Danset M, Villani AP. The use of adalimumab to overcome delayed wound healing after wide excision for hidradenitis suppurativa. Eur J Dermatol. 2024 Apr 1;34(2):200-201.
  4. Tauber M, Vocanson M. Biomarkers for chronic hand eczema: Could etiological and clinical subtypes truly be the starting point? An open question. J Eur Acad Dermatol Venereol. 2024 Jun;38(6):997-998.
  5. Lamouroux C, Bertolotti L, Coste C, Pralong P, Lefevre MA, Pasteur J, Clément A, Le Bouëdec MF, Charbotel B, Fassier JB, Vocanson M, Nicolas JF, Hacard F, Nosbaum A. Glove-related contact dermatitis: Diagnostic value of a repeated application test. Contact Dermatitis. 2024. 90(5):528-530.
  6. Quiles-Tsimaratos N, Gherardi A, Crochard A, Hueber M, Pain E, Vives A, Villani AP. The patient's perspective on the burden of psoriasis: findings based on the ROCQ, an online survey. Eur J Dermatol. 2024. 34(1):59-67.
  7. Guyénard L, Tauber M, Debord-Peguet S, Berard F, Nosbaum A, Hacard F, Castells M, Nicolas JF. Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxis. Front Allergy. 2024. 11;5:1366922.
  8. Braun C, Bourrel-Bouttaz M, Revol O, Verdu V, Montagnon A, Bérard F, Nosbaum A. Atopic Dermatitis and Self-Image Design: A Real-Life Study in Children Using Drawings. Dermatitis. 2024. 35(S1):S98-S102.
  9. Braun C, Sathasivam S, Samaan K, Graham F, Paradis L, Des Roches A, Bégin P. Severity of eczema at patch site during epicutaneous immunotherapy may predict subsequent response to oral immunotherapy. J Allergy Clin Immunol Pract. 2024. 12(4):1083-1085.e2.
  10. Ben Said B, Dupire G, Poutrel S, Jullien D. The usefulness of omalizumab in low response to corticosteroids DRESS syndrome: A case series. J Allergy Clin Immunol Pract. 2024. 12(1):236-238.
  11. Bourdonnet V, Dupire G, Calugareanu A, Boibieux A, Ben Said B. Ceftaroline-induced DRESS syndrome associated with possible lung involvement. Contact Dermatitis. 2024 Apr;90(4):423-426.
  12. Mahrous B, Dupire G, Anthony E, Ben-Said B. Acute generalized exanthematous pustulosis induced by Ambroxol confirmed by positive skin tests. Contact Dermatitis. 2024 Jan;90(1):98-99.
  13. Michallet M, Sobh M, Deloire A, Revesz D, Chelgoum Y, El-Hamri M, Barraco F, Labussiere H, Nicolini FE, Hequet O. Second line extracorporeal photopheresis for cortico-resistant acute and chronic GVHD after allogeneic hematopoietic cell transplantation for hematological malignancies: Long-term results from a real-life study. Transfus Apher Sci. 2024 Feb 16:103899.
  14. Kerrouch H, Gouillon L, Duclaux-Loras R, Burillon C, Kanitakis J, Hjira N, Guibaud L, Jullien D. Multifocal lymphangioendotheliomatosis with thrombocytopenia: Report of a case with favorable outcome into adulthood. JAAD Case Rep. 2024 May 11;49:113-116.
  15. Mosnier A, Vocanson M, Lefevre MA. Molecular profiling of skin test-induced inflammation to support the clinical diagnosis of delayed drug hypersensitivity reaction. Eur J Dermatol. 2023. 33(1):64-66.
  16. de Magalhães AR, Machado GU, Lefèvre MA, Garreau AC, Nicolas JF, Vocanson M, Mosnier A, Pralong P, Nosbaum A. T cell-and non T cell-mediated delayed hypersensitivity to dupilumab. J Eur Acad Dermatol Venereol. 2023. 37(9):e1180-e1182.
  17. Lamouroux C, Bertolotti-Potachin L, Charbotel B, Nosbaum A, Nicolas JF. Allergic contact dermatitis to diclofenac gel due to propylene glycol sensitization: usefulness of repeated open application tests to determine safer alternatives. Eur J Dermatol. 2023. 33(1):42-43.
  18. Braun C, Azzano P, Gingras-Lessard F, Roy É, Samaan K, Graham F, Paradis L, Des Roches A, Bégin P. Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI): protocol for a phase 2a randomized controlled trial. Front Med (Lausanne). 2023. 10:1198173.
  19. Braun C, Samaan K, Graham F, Paradis L, Roches AD, Bégin P. Delayed-type hypersensitivity gastrointestinal symptoms induced by food oral immunotherapy and efficiently treated by dupilumab: A case report. Pediatr Allergy Immunol. 2023. 34(3):e13935.
  20. Jullien D, Richard MA, Halioua B, Bessette C, Derancourt C, Bouloc A. The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study. Dermatol Ther (Heidelb). 2023. 13(6):1361-1376.
  21. Piotin A, Hacard F, Crumbach L, Nicolas JF, Nosbaum A. Anaphylaxis to chlorhexidine after taking oral medication. Eur J Dermatol. 2022. 32(4):551-553.
  22. Sabouraud M, Biermé P, André-Gomez SA, Villard-Truc F, Payot F, Corréard AK, Garnier L, Braun C. Real-life experience with hazelnut oral immunotherapy. Ann Allergy Asthma Immunol. 2022. 128(4):432-438.`
  23. Lefevre MA. "Prick or treat": a case of systemic reaction during intradermal tests with beta-lactams. Eur J Dermatol. 2022. 32(3):426-428.
  24. Lefevre MA, Mosnier A. A case of paracetamol-induced nonpigmented fixed drug eruption confirmed by a lymphocyte transformation test. Eur J Dermatol. 2022. 32(1):154-156.
  25. Kanitakis J, Fournier N, Jullien D. Follicular Porokeratoma: Report of a New Variant of Porokeratoma (Porokeratotic Acanthoma) and Literature Review. Am J Dermatopathol. 2022. 44(10):748-752.
  26. Richard MA, Aubin F, Beneton N, Bouloc A, Bursztejn AC, Descamps V, Jullien D. Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method. Adv Ther. 2022. 39(11):5203-5215.
  27. Fargeas M, Calugareanu A, Pascu I, Dupire G, Aubineau M, Cannas G, Ben-Said B. DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome to voxelotor treatment of sickle cell disease. J Allergy Clin Immunol Pract. 2022. 10(12):3320-3322.
  28. Fargeas M, Calugareanu A, Ben-Said B. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after topical use of Nigella sativa (black cumin) oil. Contact Dermatitis. 2022. 87(2):203-204.
  29. Calugareanu A, Grolleau C, Le Buanec H, Chasset F, Jachiet M, Battistella M, Bagot M, Jullien D, Poutrel S, Bouaziz JD, Ben Said B. Clinical efficacy of selective JAK1 inhibition and transcriptome analysis of chronic discoid lupus erythematosus. J Eur Acad Dermatol Venereol. 2022. 36(4):e308-e310.
  30. Hacard F, Giraudeau B, d'Acremont G, Jegou MH, Jonville-Bera AP, Munck S, Pham BN, Mavoungou S, Cornillier H, Guillot B, Beylot-Barry M, Chosidow O, Maruani A. Guidelines for the management of chronic spontaneous urticaria: recommendations supported by the Centre of Evidence of the French Society of Dermatology. Br J Dermatol. 2021 Sep;185(3):658-660.
  31. Bourdenet V, Jaulent C, Hacard F, Berard F, Nicolas JF, Vocanson M, Nosbaum A. Molecular analysis of an intradermal skin test to establish the diagnosis of delayed allergy to paclitaxel. Contact Dermatitis. 2021 Apr 2. doi: 10.1111/cod.13854.
  32. Villani AP, Boutroy S, Coutisson C, Carlier MC, Barets L, Marotte H, Richert B, Chapurlat RD, Jullien D, Confavreux CB. Distal phalangeal bone erosions observed by HR-pQCT in patients with psoriatic onycholysis. Rheumatology (Oxford). 2021. 60(3):1176-1184.
  33. Karrakchou B, Gouillon L, Senouci K, Kanitakis J, Jullien D. Condyloma acuminatum of the nipple, an unusual presentation. Eur J Dermatol. 2021. 31(4):586-588.
  34. Votquenne N, Dupire G, Michel O, Ben Said B. Dupilumab for severe generalized eczematous eruption complicating common variable immunodeficiency. Eur J Dermatol. 2021. 31(1):93-94.
  35. Jaulent L, Staumont-Sallé D, Tauber M, Paul C, Aubert H, Marchetti A, Sassolas B, Valois A, Nicolas JF, Nosbaum A; for GREAT Research Group. De novo psoriasis in atopic dermatitis patients treated with dupilumab: a retrospective cohort. J Eur Acad Dermatol Venereol. 2021. 35(4):e296-e297.
  36. Hequet O, Boisson C, Joly P, Revesz D, Kebaili K, Gauthier A, Renoux C, Creppy S, Nader E, Nicolas JF, Berard F, Cognasse F, Vocanson M, Bertrand Y, Connes P. Priming With Red Blood Cells Allows Red Blood Cell Exchange for Sickle Cell Disease in Low-Weight Children. Front Med (Lausanne). 2021. 8:743483.
  37. Braun C, Reix P, Durieu I, Nove-Josserand R, Durupt S, Ohlmann C, Mainguy C, Nicolas JF, Nosbaum A, Jubin V. The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work-up in cystic fibrosis patients. Pediatr Allergy Immunol. 2020. 31(4):396-404.
  38. Paul A, Braun C, Mosnier A, Lavoix A, Sagorny K, Lefebvre T, Chaigneau C, Nicolas JF, Vocanson M, Nosbaum A. Detection of skin alterations in mild-to-moderate chronic venous disease using non-invasive techniques.  Eur J Dermatol. 2020 Oct 1;30(5):505-515.
  39. Villani AP, Amatore F, Tauber M, Guillot B, Viguier M, Beylot-Barry M, Jullien D. Impact of the French guidelines on the prescribing habits of systemic treatments for moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol. 2020. 34(11):e747-e748.
  40. Chastagner M, Bouschon P, Lesort C, Kanitakis J, Jullien D. Dermpath & clinic: Pigmented epithelioid melanocytoma. Eur J Dermatol. 2020. 30(4):451.
  41. Kanitakis J, Lesort C, Danset M, Jullien D. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases. J Am Acad Dermatol. 2020. 83(3):870-875.
  42. Castagna J, Bernard L, Hacard F, Delcroix F, Darrigade AS, Nicolas JF, Decullier E, Nosbaum A, Bérard F. Clinical predictive factors of unresponsiveness to omalizumab in patients with chronic spontaneous urticaria. Br J Dermatol. 2020. 183(6):1124-1126.
  43. Pascal C, Maucort-Boulch D, Gilibert S, Bottigioli D, Verdu V, Jaulent C, Hacard F, Bérard F, Nicolas JF, Nosbaum A. Therapeutic management of adults with atopic dermatitis: comparison with psoriasis and chronic urticaria. J Eur Acad Dermatol Venereol. 2020. 34(10):2339-2345.
  44. Bérard F, Ferrier Le Bouedec MC, Bouillet L, Reguiai Z, Barbaud A, Cambazard F, Milpied B, Pelvet B, Kasujee I, Gharbi H, Lacour JP. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study. Br J Dermatol. 2019. 180(1):56-66.
  45. Chastagner M, Hoelt P, Kanitakis J, Jullien D, Villani AP. Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin. Eur J Dermatol. 2019. 29(2):218-220.
  46. Deschamps T, Nosbaum A, Delcroix F, Vocanson M, Berard F, Nicolas JF. Long-lasting allergic contact dermatitis to methylisothiazolinone misdiagnosed as atopic dermatitis. Eur J Dermatol. 2019. 29(1):100-101.
  47. Chastagner M, Hoelt P, Kanitakis J, Jullien D, Villani AP. Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin. Eur J Dermatol. 2019 Mar 2.
  48. Hequet O, Poutrel S, Connes P, Revesz D, Chelghoum Y, Kebaili K, Cannas G, Gauthier A, Guironnet-Paquet A, Vocanson M, Nicolas JF, Renoux C, Raba M, Cognasse F, Bertrand Y, Hot A, Joly P. Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients. Transfusion. 2019 Feb 12. doi: 10.1111/trf.15188.
  49. Viel S, Pescarmona R, Belot A, Nosbaum A, Lombard C, Walzer T, Bérard F. A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay. Front Immunol. 2018. 29;9:110.
  50. Castagna J, Nosbaum A, Vial T, Rozieres A, Hacard F, Vocanson M, Pralong P, Chuniaud-Louche C, Nicolas JF, Gouraud A, Bérard F. Drug-induced aseptic meningitis: A possible T-cell-mediated hypersensitivity. J Allergy Clin Immunol Pract. 2018, 6(4):1409-1411.
  51. Delaunay J, Hacard F, Denery-Papini S, Garnier L, Bérard F, Nicolas JF, Nosbaum A. Occupational immediate contact allergy to hydrolysed wheat protein after cosmetic exposure. Contact Dermatitis. 2018, 78(4):291-292.
  52. Michallet M, Sobh M, Garban F, Bulabois CE, Yakoub-Agha I, Coiteux V, Dulery R, Rohrlich PS, Legrand F, Clement L, Praire A, Detrait M, Barraco F, Nicolini FE, Hequet O. Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study. Leuk Lymphoma. 2018;59(2):372-380.
  53. Yfanti I, Nosbaum A, Berard F, Nicolas JF. Methotrexate does not impede the development of contact allergy. Contact Dermatitis. 2018 Mar;78(3):223-224.
  54. Hacard F, Martin C, Verdu V, Montagnon A, Augey F, Braire-Bourrel M, Nicolas JF, Berard F, Nosbaum A. Therapeutic patient education improves knowledge and skills for patients with chronic spontaneous urticaria. Eur J Dermatol. 2018 Dec 10. doi: 10.1684/ejd.2018.3442. [Epub ahead of print]
  55. Deschamps T, Nosbaum A, Delcroix F, Vocanson M, Berard F, Nicolas JF. Long-lasting allergic contact dermatitis to methylisothiazolinone misdiagnosed as atopic dermatitis. Eur J Dermatol. 2018, Dec 10. doi: 10.1684/ejd.2018.3456. [Epub ahead of print].

 

Clinical articles. Collaborative articles (participation as non-lead author).

  1. Refki P, Belbézier A, Lefevre MA, Vocanson M, Mosnier A, Pernollet M, Tauber M, Pralong P. Simultaneous Immediate and Delayed Hypersensitivity to Galcanezumab-Case Report. Contact Dermatitis. 2024 Dec 30. doi: 10.1111/cod.14747. Online ahead of print.
  2. Kimball AB, Bechara FG, Badat A, Giamarellos-Bourboulis EJ, Gottlieb AB, Jemec GBE, Reguiai Z, Villani AP, Alarcon I, Bansal A, Gasperoni F, Martin R, Paguet B, Uhlmann L, Zouater H, Ravichandran S, Alavi A. Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: Week 104 results from the SUNSHINE and SUNRISE extension trial. Br J Dermatol. 2024 Nov 29:ljae469.
  3. Ingram JR, Bettoli V, Espy JI, Kokolakis G, Martorell A, Villani AP, Wallinger H, Truman I, Coak E, Kasparek T, Muscianisi E, Richardson C, Kimball AB. Treatment Satisfaction in Patients with Hidradenitis Suppurativa: A Real-World Survey from the EU5 and USA. Dermatology. 2024 Nov 5:1-13.
  4. Guillemin C, Bellon N, Jachiet M, Barbarot S, Bourrat E, Chiaverini C, Cougoul P, Ebbo M, Herber M, Hubiche T, Mallet S, Tauber M, Béziat V, Castelle M, Du Thanh A, Farhi J, Fieschi C, Fournier B, Gourguechon C, Guiddir T, Lipsker D, Raison-Peyron N, Garcelon N, Cheminant M, Suarez F, Hermine O, Blanche S, Moshous D, Mahlaoui N, Neven B, Bodemer C, Lévy R, Polivka L; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP); French Atopic Dermatitis Network from the Groupe de Recherche sur l’Eczéma Atopique (GREAT). Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: A nationwide study. J Am Acad Dermatol. 2024 Sep 27:S0190-9622(24)02885-8.
  5. Bocquel S, Soria A, Raison-Peyron N, Badaoui A, Marcant P, Bara C, Giordano-Labadie F, Amsler E, Milpied B, Delaunay J, Darrigade AS, Pralong P, Boulard C, Ferrier Le Bouedec MC, Tauber M, Pasteur J, Valois A, Le Thuaut A, Crépy MN, Bernier C. Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study. J Am Acad Dermatol. 2024. 90(3):512-520.
  6. Cassagne M, Galiacy S, Kychygina A, Chapotot E, Wallaert M, Vabres B, Tauber M, Barbarot S, Paul C, Fournié P, Simon M; FRench Atopic DErmatitis Network and the Groupe de Recherche sur l'Eczema Atopique. Superficial Conjunctival Cells from Dupilumab-Treated Patients with Atopic Dermatitis with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature.  J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02102-X.
  7. Strizzolo R, Seneschal J, Soria A, Staumont-Sallé D, Barbarot S, Viguier M, Jachiet M, Nosbaum A, Clément A, Tauber M, Mallet S, Du-Thanh A; French Atopic Dermatitis Network from the GREAT Research group. Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab. World Allergy Organ J. 2024 Jul 4;17(7):100923.
  8. Kpenou FC, Paul C, Seneschal J, Andreu N, Barbarot S, Tauber M, Natella PA, Shourick J, Ezzedine K. The Atopic Dermatitis Patient Journey: Insights from a Qualitative Study. Br J Dermatol. 2024 Aug 18:ljae329.
  9. Dupuis J, Tauber M, Mahe E, Jachiet M, Soria A, Tetart F, Puzenat E, Pasteur J, Raison-Peyron N, Giordano-Labadie F, Droitcourt C, Leleu C, Nosbaum A, Aubert H, Moigne MLE, Bernier C, Barbarot S, Ezzedine K, Diaz E, Hubiche T, Faiz S, Azib S, Dezoteux F, Chosidow O, Staumont-Salle D; French Atopic Dermatitis Network from the Group of Research and Study in Atopic Dermatitis (GREAT), the French Society of Dermatology (SFD). Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity. J Eur Acad Dermatol Venereol. 2024 Jul 31. doi: 10.1111/jdv.20264.
  10. Poizeau F, Leducq S, Fardet L, Beylot-Barry M, Chaby G, Chastagner M, Corgibet F, Gouillon L, Jouan N, Jullien D, Acher A, Amatore F, Amici JM, Aubert H, Aubin F, Beneton N, Bouilly D, Bursztejn AC, Buzenet C, Chamaillard-Pujol M, Charles J, Cottencin-Charriere AC, Duval Modeste B, Fauconneau A, Fougerousse AC, Girard C, Goujon C, Khemis A, Le Ru Y, Lepelley-Dupont C, Mahé E, Marcellin X, Nicolas C, Pallure V, Parier J, Quiles N, Stoebner PE, Tauber M, Vermersch A, Viguier M, Villani AP, Chosidow O, Guillot B; Psoriasis Research Group (GRPso) and the Centre of Evidence of the French Society of Dermatology. Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm. Ann Dermatol Venereol. 2024 Sep;151(3):103287. doi: 10.1016/j.annder.2024.103287.
  11. Pierrard G, Bernier C, Du-Thanh A, Bara C, Soria A, Castelain F, Boccon-Gibod I, Hacard F, Delaunay J, de Montjoye L, Staumont-Salle D, Dezoteux F. Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study. Allergy. 2024 Sep;79(9):2448-2457.
  12. Benmoussa K, Bernaudin F, Connes P, Héquet O, Joseph L, Beraud M, Bah A. Position paper on advancing sickle cell disease management in France by bridging the clinical practices and guidelines through expert insights. Transfus Apher Sci. 2024 Oct;63(5):103988.
  13. Clark R, Davies S, Labrador J, Loubet P, Natalini Martínez S, Moríñigo HM, Nicolas JF, Vera MP, Rämet M, Rebollo-Rodrigo MH, Sanz-Muñoz I, Dezutter N, Germain S, David MP, Jayadev A, Amare Hailemariam H, Kotb S, Meyer N. Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial. Clin Infect Dis. 2024 Oct 15;79(4):1088-1098.
  14. Tanno LK, Perie A, Bernstein JA, Sublett JL, Davtyan K, Berard F, Pawankar R, Valentin Rostan M, Chong H, Yañez A, Ansontegui IJ, Ebisawa M, Wong GWK, Morais-Almeida M, Martin B, Briand Y, Demoly P; American Academy of Allergy Asthma & Immunology (AAAAI); American College of Allergy Asthma and Immunology (ACAAI); Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI); French Allergy Society (SFA); French WHO Collaborating Centre; WHO Regional Office for Europe; Latin American Society of Allergy and Immunology (SLAAI); Montpellier WHO Collaborating Centre; World Allergy Organization (WAO). Allergic and hypersensitivity condition in the International Patients' Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11. World Allergy Organ J. 2024 Aug 20;17(8):100921.
  15. Khanafer N, Oudot S, Maligeay M, Planckaert C, Mena C, Mandel NT, Bouhalila R, Ader F, Berard F, Bouhour F, Chapurlat R, Charriere S, Confavreux C, Devouassoux G, Disse E, Fouque D, Ghesquieres H, Hyvert S, Jolivot A, Durand A, Martin-Gaujard G, Mornex JF, Nicolino M, André-Obadia N, Raverot G, Reix P, Ruffion A, Seve P, Hermann R, Zoulim F, Clamens J, Ayala MP, Vanhems P. A quick access to information on influenza burden and prevention in Lyon university hospital: A prospective QR code-based information campaign in 2022-2023. Vaccine. 2024 Aug 30;42(21):126160.
  16. Tran C, Mahé E, Beylot-Barry M, Jullien D, Richard MA, Fougerousse AC, Bouznad A, Bulai Livideanu C, Brun A, Amelot F, Maccari F, Aubin F, Benhadou F, Paul C. Real-life management of psoriasis with biological agents during pregnancy. Ann Dermatol Venereol. 2024 Jun;151(2):103254
  17. Cuny T, Reynaud R, Raverot G, Coutant R, Chanson P, Kariyawasam D, Poitou C, Thomas-Teinturier C, Baussart B, Samara-Boustani D, Feuvret L, Villanueva C, Villa C, Bouillet B, Tauber M, Espiard S, Castets S, Beckers A, Amsellem J, Vantyghem MC, Delemer B, Chevalier N, Brue T, André N, Kerlan V, Graillon T, Raingeard I, Alapetite C, Raverot V, Salenave S, Boulin A, Appay R, Dalmas F, Fodil S, Coppin L, Buffet C, Thuillier P, Castinetti F, Vogin G, Cazabat L, Kuhn E, Haissaguerre M, Reznik Y, Goichot B, Bachelot A, Kamenicky P, Decoudier B, Planchon C, Micoulaud-Franchi JA, Romanet P, Jacobi D, Faucher P, Carette C, Bihan H, Drui D, Rossignol S, Gonin L, Sokol E, Wiard L, Courtillot C, Nicolino M, Grunenwald S, Chabre O, Christin-Maître S, Desailloud R, Maiter D, Guignat L, Brac de la Perrière A, Salva P, Scavarda D, Bonneville F, Caron P, Vasiljevic A, Cortet C, Gaillard S, Albarel F, Clément K, Jouanneau E, Dufour H, Barat P, Gatta-Cherifi B. Diagnosis and management of children and adult craniopharyngiomas: a French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes Consensus Statement. Ann Endocrinol (Paris). 2024 Jul 11:S0003-4266(24)00108-2.
  18. Ingen-Housz-Oro S, Matei I, Gaillet A, Gueudry J, Zaghbib K, Assier H, Hua C, Bensaid B, Colin A, Ouedraogo R, Redlich J, Courtois E, Chazelas K, Sbidian E, Nakad L, Bequignon E, Terkmane N, Gaultier F, Schlemmer F, Do-Pham G, Barbaud A, Lebrun-Vignes B, Hoffmann C, Mahé PJ, Le Floch R, Bernier C, Vabres B, Milpied B, Delcampe A, Tétart F, Tauber M, Staumont-Sallé D, Dezoteux F, Descamps V, Misery L, Bursztejn AC, Dereure O, Amazan E, Le Bidre E, Le Pallec S, Lagier C, Laroche A, Ferrat E, Wolkenstein P, de Prost N; French National Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL. French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis). Ann Dermatol Venereol. 2024 Jun;151(2):103282.
  19. Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials. Lancet. 2024. 403(10422):147-159.
  20. Passeron T, Perrot JL, Jullien D, Goujon C, Ruer M, Boyé T, Villani AP, Quiles Tsimaratos N. Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab. JAMA Dermatol. 2024. 160(2):199-203.
  21. Le Baron Q, Bourneau-Martin D, Babin M, Gouraud A, Tauber M, Fresse A, Lebrun-Vignes B, Delaunay J, Morisset M, Briet M. Cross-reactivity among and between macrolides, lincosamides, and streptogramins: Study on the French pharmacovigilance database. Fundam Clin Pharmacol. 2024. doi: 10.1111/fcp.13005.
  22. Tedbirt B, Maho-Vaillant M, Houivet E, Mignard C, Golinski ML, Calbo S, Prost-Squarcioni C, Labeille B, Picard-Dahan C, Chaby G, Richard MA, Tancrede-Bohin E, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Musette P, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Joly P, Hébert V; French Reference Center for Autoimmune Blistering Diseases MALIBUL. Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial. JAMA Dermatol. 2024. 160(3):290-296.
  23. Poizeau F, Maruani A, Staumont-Sallé D, Jouan N, Ly S, Schollhammer M, Reverte M, Dibao-Dina C, Duong TA, Matard B, Penso-Assathiany D, Dupuy A, Carriot M, Seï JF, Corgibet F, Guillot B, Barbarot S, Leducq S, Bertolotti A, Tannous J, Chaby G, Jullien D, Pépin E, Quéreux G, Beylot-Barry M, Chosidow O; Centre of Evidence of the French Society of Dermatology. Promoting clinical research in community-based practice: Threats and opportunities. Ann Dermatol Venereol. 2024 Jun;151(2):103272.
  24. Lio PA, Armstrong A, Gutermuth J, Nosbaum A, Sofen H, Gil EG, Casillas M, Chen S, Sun L, Pierce E, Elmaraghy H, Dawson Z, Torres T. Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis. Dermatol Ther (Heidelb). 2024 Jul;14(7):1929-1943.
  25. Tetart F, Walsh S, Milpied B, Gaspar K, Vorobyev A, Tiplica GS, Didona B, Welfringer-Morin A, Kucinskiene V, Bensaid B, Marvanova E, Salavastru C, Brezinova E, Chua SL, Lovgren ML, Hammers CM, Barbaud A, Mortz CG, Horvath B, Meyersburg D, Lebrun-Vignes B, Bodemer C, Brüggen MC, French LE, Ingen-Housz-Oro S. Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management. J Eur Acad Dermatol Venereol. 2024 Nov;38(11):2073-2081.
  26. Klepfisch L, Ben-Said B, Ribereau-Gayon E, Kanitakis J, Danset M. Line-field confocal optical coherence tomography for real-time differential diagnosis of toxic epidermal necrolysis versus staphylococcal scalded skin syndrome. Clin Exp Dermatol. 2024 Nov 22;49(12):1704-1707.
  27. Ingen-Housz-Oro S, Guichard E, Milpied B, Bensaid B, Collet E, Barbaud A, Le Duff F, Tétart F, Soria A, Machet L, Descamps V, Monestier S, Pasteur J, Morice C, Chaby G, Colin A, Grégoire L, Allanore L, Giraudeau B, Chosidow O. Topical versus oral corticosteroids in moderate drug reaction with eosinophilia and systemic symptoms: A multicenter randomized clinical trial. J Am Acad Dermatol. 2024 Sep;91(3):544-547.
  28. Simpson EL, Silverberg JI, Nosbaum A, Winthrop K, Guttman-Yassky E, Hoffmeister KM, Egeberg A, Valdez H, Fan H, Farooqui SA, Chan G, Alderfer J, Romero W, Chittuluru K. Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure. Am J Clin Dermatol. 2024 Jul;25(4):639-654.
  29. Gorochov G, Ropers J, Launay O, Dorgham K, da Mata-Jardin O, Lebbah S, Durier C, Bauer R, Radenne A, Desaint C, Vieillard LV, Rekacewicz C, Lachatre M, Parfait B, Batteux F, Hupé P, Ninove L, Lefebvre M, Conrad A, Dussol B, Maakaroun-Vermesse Z, Melica G, Nicolas JF, Verdon R, Kiladjian JJ, Loubet P, Schmidt-Mutter C, Dualé C, Ansart S, Botelho-Nevers E, Lelièvre JD, de Lamballerie X, Kieny MP, Tartour E, Paul S. Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination. JAMA Netw Open. 2024. 7(4):e248051.
  30. Durier C, Ninove L, van der Werf S, Lefebvre M, Desaint C, Bauer R, Attia M, Lecompte AS, Lachatre M, Maakaroun-Vermesse Z, Nicolas JF, Verdon R, Kiladjian JJ, Loubet P, Schmidt-Mutter C, Corbin V, Ansart S, Melica G, Resch M, Netzer E, Kherabi Y, Tardieu R, Lelièvre JD, Tartour E, Meyer L, de Lamballerie X, Launay O; ANRS002S CoviCompareP group. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Infect Dis Now. 2024 Mar 16;54(5):104886.
  31. Puri A, Pollard AJ, Schmidt-Mutter C, Lainé F, PrayGod G, Kibuuka H, Barry H, Nicolas JF, Lelièvre JD, Sirima SB, Kamala B, Manno D, Watson-Jones D, Gaddah A, Keshinro B, Luhn K, Robinson C, Douoguih M; EBL4001 Study Group. Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study. Vaccines (Basel). 2024. 12(2):210.
  32. Elbany C, Braun C, Lazizi S, Paradis L, Des Roches A, Samaan K, Labrosse R, Graham F, Bégin P. Effect-modifying impact of age on sex-based differences during oral immunotherapy. Allergy. 2024. 79(2):526-529.
  33. Chircop I, Reynaud V, Villani AP, Chastagner M. When a molecular signature helps to manage a case of eosinophilic dermatosis. Eur J Dermatol. 2023. 33(5):573-574.
  34. Augustin M, Nosbaum A, Werfel T, Grond S, Reed C, Lampropoulou A, Tietz N, Irvine AD, Riedl E. Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international patient survey. J Dermatolog Treat. 2023. 34(1):2276047.
  35. Merola JF, Chiou AS, During E, Costanzo A, Foley P, Alfalasi A, Gogate S, Pinter A, Dodiuk-Gad R, Simon D, Tauber M, Weller R, Pereyra-Rodriguez JJ, Ardeleanu M, Wu J, Ozturk ZE. Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study. Br J Dermatol. 2023. 189(6):685-694.
  36. Thyssen JP, Bieber T, Kleyn CE, Nosbaum A, Grond S, Petto H, Riedl E, Wollenberg A. Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis. J Dermatolog Treat. 2023. 34(1):2216322.
  37. Lessard LER, Tard C, Salort-Campana E, Sacconi S, Béhin A, Bassez G, Orlikowski D, Merle P, Nollet S, Gallay L, Bérard F, Robinson P, Bouhour F, Laforêt P. Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease: An experience from the French Pompe Registry. Mol Genet Metab. 2023. 139(3):107611.
  38. Fottorino A, Richard MA, Prouteau C, Balland C, Villani AP, Buche S, Hotz C, Delage M, Nassif A, Cogrel O, Jouan N. Hidradenitis suppurativa: Impact of the French guidelines on dermatology practices. Ann Dermatol Venereol. 2023. 150(3):227-229.
  39. Ebermeyer T, Hequet O, Berard F, Prier A, Eyraud MA, Arthaud CA, Heestermans M, Duchez AC, Guironnet-Paquet A, Berthelot P, Cognasse F, Hamzeh-Cognasse H. The efficacy of therapeutic plasma exchange in COVID-19 patients on endothelial tightness in vitro is hindered by platelet activation. Front Cardiovasc Med. 2023. 10:1094786.
  40. François M, Daubin D, Menouche D, Gaillet A, Provoost J, Trusson R, Arrestier R, Hequet O, Richard JC, Moranne O, Larcher R, Klouche K. Adverse Events and Infectious Complications in the Critically Ill Treated by Plasma Exchange: A Five-Year Multicenter Cohort Study. Crit Care Explor. 2023. 5(11):e0988.
  41. Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG, Paul C, Giamarellos Bourboulis EJ, Villani AP, Schwinn A, Ruëff F, Pillay Ramaya L, Reich A, Lobo I, Sinclair R, Passeron T, Martorell A, Mendes-Bastos P, Kokolakis G, Becherel PA, Wozniak MB, Martinez AL, Wei X, Uhlmann L, Passera A, Keefe D, Martin R, Field C, Chen L, Vandemeulebroecke M, Ravichandran S, Muscianisi E. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials. Lancet. 2023. 401(10378):747-761.
  42. Clément A, Ferrier le Bouëdec MC, Crépy MN, Raison-Peyron N, Tétart F, Marcant P, Pralong P, Valois A, Pasteur J, Assier H, Bernier C, Le Cam MT, Hacard F, Nosbaum A, Giordano Labadie F, Morice C, Leleu C, Milpied B, Darrigade AS, Delaunay J, Barbaud A, Castelain F, Collet E, Amsler E; from the Dermatology and Allergology group of the French Society of Dermatology (DAG). Hand eczema in glove-wearing patients. Contact Dermatitis. 2023. 89(3):143-152.
  43. Lejay S, Darrigade AS, Dupre D, Méry S, Verdu V, Stalder JF, Nosbaum A; Eczema Foundation and the French Group on Therapeutic Education in Dermatology (GET). Use of therapeutic patient education tools for atopic dermatitis: A French national survey. J Eur Acad Dermatol Venereol. 2023. 37(11):e1271-e1273.
  44. Costedoat I, Wallaert M, Gaultier A, Vasseur R, Vanhaecke C, Viguier M, Cordelette C, Denoyer A, Ferrier le Bouëdec MC, Coutu A, Lamiaux M, Tran THC, Lacour JP, Elmaleh V, Tetart F, Gueudry J, Tauber M, Giordano-Labadie F, Cassagne M, Nosbaum A, Ouilhon C, Jachiet M, Tadayoni R, Dezoteux F, Staumont-Salle D, Bouleau J, Labalette P, Doan S, Soria A, Mortemousque B, Seneschal J, Barbarot S; FRench Atopic DErmatitis Network from the Groupe de Recherche sur l'Eczema Atopique (GREAT), France. Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients. J Eur Acad Dermatol Venereol. 2023. 37(5):1056-1063.
  45. Grolleau C, Calugareanu A, Demouche S, Nosbaum A, Staumont-Sallé D, Aubert H, Cassius C, Jachiet M, Saussine A, Bagot M, Bachelez H, Battistella M, Hotz C, Du Thanh A, Crépy MN, Bergerat D, Merandet M, Onifarasoaniaina R, Alberdi A, How-Kit A, Bouaziz JD, Le-Buanec H. IL-4/IL-13 Inhibitors for Atopic Dermatitis Induce Psoriatic Rash Transcriptionally Close to Pustular Psoriasis. J Invest Dermatol. 2023. 143(5):711-721.e7.
  46. Vanlerberghe J, Dezoteux F, Martin C, Jachiet M, Soria A, Tétart F, Modeste-Duval AB, Bursztejn AC, Misery L, Aubin F, Lasek A, Leleu C, Du-Thanh A, Pasteur J, Pralong P, Nosbaum A, Droitcourt C, Viguier M, Tauber M, Seneschal J, Barbarot S, Staumont-Sallé D. Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. J Am Acad Dermatol. 2023. 88(4):900-904.
  47. Voland P, Barthel C, Azzouz B, Raison-Peyron N, Du-Thanh A, Staumont-Sallé D, Jachiet M, Soria A, Nosbaum A, Valois A, Leleu C, Lebrun-Vignes B, Trenque T, Hettler D, Bernier C, Viguier M; French Group of Research and Study in Atopic Eczema (GREAT) of the French Society of Dermatology. Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study. J Am Acad Dermatol. 2023. 88(2):380-387.
  48. Damoisy JB, Destombes V, Savina Y, Pröpper CJ, Braun C, Tanné C. Epidemiology, prevention methods, and risk factors of foot blisters in French trail ultramarathons. J Sports Med Phys Fitness. 2023. 63(8):921-926.
  49. Litovsky J, Hacard F, Tétart F, Boccon-Gibod I, Soria A, Staumont-Sallé D, Doutre MS, Amsler E, Mansard C, Dezoteux F, Darrigade AS, Milpied B, Bernier C, Perrot JL, Raison-Peyron N, Paryl M, Droitcourt C, Demoly P, Grosjean J, Mura T, Du-Thanh A; Urticaria Study Group of French Dermatology Society. Omalizumab Drug Survival in Chronic Urticaria: A Retrospective Multicentric French Study. J Allergy Clin Immunol Pract. 2023. 11(12):3752-3762.e2.
  50. Salle R, Tubach F, Arlegui H, Curmin R, Viguier M, Beylot-Barry M, Dupuy A, Beneton N, Joly P, De Rycke Y, Jullien D, Mahé E, Paul C, Richard MA, Bachelez H, Zago M, Chosidow O, Sbidian É; PsoBioTeq. Clinical features, therapeutic choice and response by phototype in psoriasis: analysis of the French PsoBioTeq cohort. Clin Exp Dermatol. 2023. 48(11):1238-1246.
  51. Egeberg A, Jullien D, Gaarn Du Jardin K, Thaçi D. Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adverse events of special interest. J Dermatolog Treat. 2023. 34(1):2220447.
  52. Quirke-McFarlane S, Weinman J, Cook ES, Yiu ZZN, Dand N, Langan SM, Bechman K, Tsakok T, Mason KJ, McAteer H, Meynell F, Coker B, Vincent A, Urmston D, Vesty A, Kelly J, Lancelot C, Moorhead L, Barbosa IA, Bachelez H, Capon F, Contreras CR, De La Cruz C, Di Meglio P, Gisondi P, Jullien D, Lambert J, Naldi L, Puig L, Spuls P, Torres T, Warren RB, Waweru H, Galloway JB, Griffiths CEM, Barker JN, Norton S, Smith CH, Mahil SK; PsoProtect study group. Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey. Br J Dermatol. 2023. 188(5):610-617.
  53. Aubert H, Arlegui H, De Rycke Y, Bachelez H, Beylot-Barry M, Dupuy A, Joly P, Jullien D, Mahé E, Paul C, Richard MA, Sbidian E, Viguier M, Chosidow O, Tubach F, Bénéton N; PsoBioTeq Study Group. Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry. Br J Dermatol. 2023. 188(1):150-152.
  54. Koren J, Lambert JLW, Thomsen SF, McAteer H, Fabbrocini G, Corazza V, Jullien D, Augustin M, Warren RB, de Rie MA, Lazaridou E, Puig L, Guillevin L, Grosser M, Boehncke WH. Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative. Dermatol Ther (Heidelb). 2023. 13(1):245-268.
  55. Mrowietz U, Barker J, Conrad C, Jullien D, Gisondi P, Flower A, Reddy J, Paris M, Picard H, Jardon S, Augustin M. Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial. J Eur Acad Dermatol Venereol. 2023. 37(2):348-355.
  56. Ahouach B, Diaz E, Bertin B, Ben Said B, Combret S, Grandvuillemin A, Petitpain N, Rabier MB, Thomas L, Trenque T, Ingen-Housz-Oro S, Lebrun-Vignes B. Epidermal necrolysis after COVID-19 vaccination: An exploratory analysis using World Health Organization VigiBase. J Eur Acad Dermatol Venereol. 2023. 37(4):e456-e459.
  57. Guédon C, Tauber M, Linder C, Paul C, Shourick J. Real-life long-term efficacy of dupilumab in adults with moderate to severe atopic dermatitis: Results of a cohort study. Ann Dermatol Venereol. 2023 Sep;150(3):215-216.
  58. Massy EF, Confavreux CB, Ammari K, Ramos J, Roger C, Villani AP, Chikh K. Untargeted metabolomics profiling identifies onycholysis-specific signature in psoriasis. Joint Bone Spine. 2022. 89(6):105410.
  59. Karabajakian A, Garrivier T, Crozes C, Gadot N, Blay JY, Bérard F, Céruse P, Zrounba P, Saintigny P, Mastier C, Fayette J. Addendum: Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma. Oncotarget. 2022. 13:1305
  60. Ingram JR, Bettoli V, Espy JI, Kokolakis G, Martorell A, Villani AP, Wallinger H, Coak E, Kasparek T, Muscianisi E, Richardson C, Kimball AB. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US. J Eur Acad Dermatol Venereol. 2022. 36(9):1597-1605.
  61. Beaumont C, Darrigade AS, Barbaud A, Collet E, Raison-Peyron N, Bourrain JL, Assier H, Giordano-Labadie F, Bara-Passot C, Milpied B, Tétart F, Armingaud P, Castelain F, Benkalfate L, Boulard C, Delaunay J, Mathelier-Fusade P, Pecquet C, Pralong P, Vital-Durand D, Genillier Foin N, Lefèvre MA, Hacard F, Nosbaum A, Pasteur J, Valois A, Vigan M, Ferrier le Bouëdec MC; REVIDAL-GERDA Network. Multiple cases of sensitization to an antiseptic containing chlorhexidine digluconate/benzalkonium chloride/benzyl alcohol with different profiles of sensitization in adults and children. Contact Dermatitis. 2022. 87(1):62-70.
  62. Weidinger S, Nosbaum A, Simpson E, Guttman E. Good practice intervention for clinical assessment and diagnosis of atopic dermatitis: Findings from the atopic dermatitis quality of care initiative. Dermatol Ther. 2022. 35(3):e15259.
  63. Dubromel A, Caffin AG, Hacard F, Vantard N, Baudouin A, Herledan C, Larbre V, Schwiertz V, Nosbaum A, Pralong P, Nicolas JF, Berard F, Rioufol C, Ranchon F. Preparations of exploration of immediate hypersensitivity to antineoplastic agents: An oncology pharmacy perspective. J Oncol Pharm Pract. 2022. 28(7):1552-1559.
  64. Du-Thanh A, Soria A, Amsler E, Badaoui A, Doutre MS, Gabison G, Bernier C, Staumont-Sallé D, Hacard F, Castelain F, Darrigade AS, Tapsoba GPM, Sarre ME, Mathelier-Fusade P, Delaunay J, Pralong P, Barbaud A, Dezoteux F, Trémeau-Martinage C, Bachtarzi Z, Augey F; Urticaria Group of the French Society of Dermatology. Discrepancies in the management of acquired cold contact urticaria: Results of a French-speaking urticaria experts questionnaire survey. World Allergy Organ J. 2022. 15(9):100688.
  65. Roubertou Y, Mainbourg S, Hot A, Fouque D, Confavreux C, Chapurlat R, Debarbieux S, Jullien D, Sève P, Juillard L, Kolopp-Sarda MN, Lega JC. Cryoglobulinemia in systemic lupus erythematosus: a retrospective study of 213 patients. Arthritis Res Ther. 2022. 24(1):167.
  66. Bechman K, Cook ES, Dand N, Yiu ZZN, Tsakok T, Meynell F, Coker B, Vincent A, Bachelez H, Barbosa I, Brown MA, Capon F, Contreras CR, De La Cruz C, Meglio PD, Gisondi P, Jullien D, Kelly J, Lambert J, Lancelot C, Langan SM, Mason KJ, McAteer H, Moorhead L, Naldi L, Norton S, Puig L, Spuls PI, Torres T, Urmston D, Vesty A, Warren RB, Waweru H, Weinman J, Griffiths CEM, Barker JN, Smith CH, Galloway JB, Mahil SK; PsoProtect study group. Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey. Br J Dermatol. 2022. 187(2):254-256
  67. Zheng M, Jullien D, Eyerich K. The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis. Am J Clin Dermatol. 2022. 23(Suppl 1):5-12.
  68. Letarouilly JG, Pham T, Pierache A, Acquacalda É, Banneville B, Barbarot S, Baudart P, Bauer É, Claudepierre P, Constantin A, Dernis E, Felten R, Gaudin P, Girard C, Gombert B, Goupille P, Guennoc X, Henry-Desailly I, Jullien D, Karimova E, Lanot S, Le Dantec L, Pascart T, Plastaras L, Sultan N, Truchet X, Varin S, Wendling D, Gaboriau L, Staumont-Sallé D, Peyrin-Biroulet L, Flipo RM. New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL study. Rheumatology (Oxford). 2022. 61(7):2848-2855.
  69. Roux C, Ben Said B, Milpied B, Bernier C, Staumont-Sallé D, Dezoteux F, Soria A, Barbaud A, Valeyrie-Allanore L, Tétart F, Bellon N, Lebrun-Vignes B, Gener G, Paul M, Ingen-Housz-Oro S, Assier H. Skin Testing and Drug Provocation Tests in Epidermal Necrolysis: A French Experience. J Allergy Clin Immunol Pract. 2022. 10(12):3252-3261.e2.
  70. Bedouelle E, Ben Said B, Tetart F, Milpied B, Welfringer-Morin A, Maruani A, Catteau B, Dezoteux F, Staumont-Sallé D, Mazereeuw-Hautier J, Abasq C, Chiaverini C, Delaunay J, Mallet S, Sterling B, Puzenat E, Raynal M, Collet E, Bernier C; Groupe FISARD de la Société Française de Dermatologie and the Groupe de Recherche de la Société Française de Dermatologie Pédiatrique. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases. J Allergy Clin Immunol Pract. 2022. 10(1):267-274.e5.
  71. Durier C, Ninove L, Lefebvre M, Radenne A, Desaint C, Ropers J, Bauer R, Lebbah S, Carette D, Lachatre M, Lecompte AS, Deplanque D, Botelho-Nevers E, Conrad A, Dussol B, Maakaroun-Vermesse Z, Melica G, Nicolas JF, Verdon R, Kiladjian J, Loubet P, Schmidt-Mutter C, Dualé C, Ansart S, Priet S, Levier A, Molino D, Vieillard LV, Parfait B, Lelièvre JD, Tartour E, de Lamballerie X, Launay O; ANRS0002S CoviCompareP Group; AP-HP CoviCompareM Group; Biological resource centers; Laboratories; Trial coordination; Sponsor; Scientific Committee. Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years. Sci Rep. 2022. 12(1):20373.
  72. Cognasse F, Hamzeh-Cognasse H, Duchez AC, Shurko N, Eyraud MA, Arthaud CA, Prier A, Heestermans M, Hequet O, Bonneaudeau B, Rochette-Eribon S, Teyssier F, Barlet-Excoffier V, Chavarin P, Legrand D, Richard P, Morel P, Mooney N, Tiberghien P. Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology. Front Immunol. 2022. 13:1034379.
  73. Dumortier J, Chouik Y, Hequet O, Hervieu V, Boillot O. Rituximab and plasmapheresis for severe post-transplant auto-immune hepatitis. Clin Res Hepatol Gastroenterol. 2022 Mar;46(3):101844.
  74. Garreau AC, Kanitakis J, Jullien D, Lesort C. Dermpath & Clinic: Cellular neurothekeoma mimicking pyogenic granuloma. Eur J Dermatol. 2021. 31(4):585-586.
  75. Patras M, Decullier E, Lebbé C, Delyon J, Dantal J, Legendre C, Mazloum M, Du Thanh A, Boukari F, Morelon E, Jullien D, Kanitakis J, Ducroux E. Outcome of pretransplant melanoma after solid organ transplantation: an observational study. Transpl Int. 2021. 34(11):2154-2165.
  76. Tournadre A, Sellam J, Morel J, Jullien D, Richez C, Pham T; CRI, GrPSo and all the expert contributors. Practical management of patients on anti-IL17 therapy - the CRI guidelines. Joint Bone Spine. 2021. 88(3 Suppl 1):105209.
  77. Su JC, Murashkin N, Wollenberg A, Svensson Å, Chernyshov P, Lio P, Murrell D, Nosbaum A, Faure S, Mery S, Stalder JF. Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis: An international, cross-sectional study. JAAD Int. 2021. 4:13-14.
  78. Tournadre A, Sellam J, Morel J, Jullien D, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Goupille P, Kluger N, Lazaro E, Goff BL, Lédinghen V, Lequerré T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Richez C, Pham T. Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine. 2021. 88(3 Suppl 1):105210.
  79. Danset M, Lesort C, Jullien D, Kanitakis J. Cutaneous calciphylaxis of the glans penis presenting as a gangrenous ulceration. Dermatol Online J. 2021. 27(4):13030/qt7ng3v2bf.
  80. Sellam J, Morel J, Tournadre A, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Dieudé P, Goupille P, Jullien D, Kluger N, Lazaro E, Le Goff B, de Lédinghen V, Lequerré T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Pham T, Richez C. PRACTICAL MANAGEMENT of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine. 2021. 88(2 Suppl 1):105174.
  81. Lesort C, Fattouh K, Jullien D, Kanitakis J. A recent nodule on the forehead. Eur J Dermatol. 2021. 31(1):117-119.
  82. Eichenfield LF, Kusari A, Han AM, Barbarot S, Deleuran M, Lio P, Marcoux D, Nosbaum A, Stalder JF. Therapeutic education in atopic dermatitis: A position paper from the International Eczema Council. JAAD Int. 2021. 3:8-13.
  83. Simpson EL, Silverberg JI, Nosbaum A, Winthrop KL, Guttman-Yassky E, Hoffmeister KM, Egeberg A, Valdez H, Zhang M, Farooqui SA, Romero W, Thorpe AJ, Rojo R, Johnson S. Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program. Am J Clin Dermatol. 2021. 22(5):693-707.
  84. Tanno LK, Berard F, Beaudoin E, Didier A, Demoly P. SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center. Vaccines (Basel). 2021. 9(6):560.
  85. Yailian AL, Gardes S, Delcroix F, Nosbaum A, Chambrier C, Carré E. [Tolerance and effectiveness of an alcoholic solution of 2% chlorhexidine in patients with a long-term central venous route.] Soins. 2021. 66(854):10-15.
  86. Bruin-Weller M, Pink AE, Patrizi A, Gimenez-Arnau AM, Agner T, Roquet-Gravy PP, Ferrucci SM, Arenberger P, Svensson A, Schuttelaar MLA, Nosbaum A, Jayawardena S, Rizova E, Ardeleanu M, Eckert L, Ozturk ZE. Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study. J Dermatolog Treat. 2021. 32(2):164-173.
  87. Condamina M, Penso L, Tran VT, Hotz C, Guillem P, Villani AP, Perrot P, Bru MF, Jacquet E, Nassif A, Bachelez H, Wolkenstein P, Beylot-Barry M, Richard MA, Ravaud P, Viguier M, Sbidian E. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts. Dermatology. 2021. 237(5):748-758.
  88. Cordel N, Derambure C, Coutant S, Mariette X, Jullien D, Debarbieux S, Chosidow O, Meyer A, Bessis D, Joly P, Mathian A, Levesque H, Sabourin JC, Tournier I, Boyer O; OncoMyositis Study group. TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1γ positive cancer-associated dermatomyositis. Rheumatology (Oxford). 2021. 60(12):5863-5867.
  89. Misery L, Shourick J, Sénéschal J, Paul C, de Pouvourville G, Jullien D, Mahé E, Bachelez H, Aubert R, Joly P, Héas S, Reguiai Z, Ezzedine K, Taieb C, Richard MA. Use of Complementary and Alternative Medicines by Patients with Psoriasis: Results from a Study with 2562 Patients. Am J Clin Dermatol. 2021. 22(2):285-287.
  90. Lefèvre-Utile A, Braun C, Haftek M, Aubin F. Five Functional Aspects of the Epidermal Barrier. Int J Mol Sci. 2021. 22(21):11676.
  91. Assan F, Tubach F, Arlegui H, Viguier M, Beylot-Barry M, Dupuy A, Beneton N, Joly P, Jullien D, Mahé E, Paul C, Richard MA, Bachelez H, Giboin C, Chosidow O, Sbidian E; and Psobioteq. First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq. Dermatology. 2021. 237(3):338-346.
  92. Anci E, Braun C, Marinosci A, Rodieux F, Midun E, Torres MJ, Caubet JC. Viral Infections and Cutaneous Drug-Related Eruptions. Front Pharmacol. 2021. 11:586407.
  93. Mahil SK, Dand N, Mason KJ, Yiu ZZN, Tsakok T, Meynell F, Coker B, McAteer H, Moorhead L, Mackenzie T, Rossi MT, Rivera R, Mahe E, Carugno A, Magnano M, Rech G, Balogh EA, Feldman SR, De La Cruz C, Choon SE, Naldi L, Lambert J, Spuls P, Jullien D, Bachelez H, McMahon DE, Freeman EE, Gisondi P, Puig L, Warren RB, Di Meglio P, Langan SM, Capon F, Griffiths CEM, Barker JN, Smith CH; PsoProtect study group. Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study. J Allergy Clin Immunol. 2021. 147(1):60-71.
  94. Giordano-Labadie F, Becherel PA, Pralong P, Outtas O, Ruer-Mulard M, Berard F, Greco M, Lacour JP, Debons-Peyroutet M, Pelvet B, Lamirand A, Guillet G. Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study. Eur J Dermatol. 2021. 31(2):217-224.
  95. Danset M, Hacard F, Jaulent C, Nosbaum A, Berard F, Nicolas JF, Goujon C. Brodalumab-associated generalized eczematous eruption in a difficult-to-treat psoriasis patient: management without brodalumab withdrawal. Eur J Dermatol. 2020. 30(6):741-743.
  96. Girolomoni G, Luger T, Nosbaum A, Gruben D, Romero W, Llamado LJ, DiBonaventura M. The Economic and Psychosocial Comorbidity Burden Among Adults with Moderate-to-Severe Atopic Dermatitis in Europe: Analysis of a Cross-Sectional Survey. Dermatol Ther (Heidelb). 2021. 11(1):117-130.
  97. Pepin S, Nicolas JF, Szymanski H, Leroux-Roels I, Schaum T, Bonten M, Icardi G, Shrestha A, Tabar C; QHD00011 study team. Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial. Hum Vaccin Immunother. 2021 Dec 2;17(12):5475-5486.
  98. Sesques P, Tordo J, Ferrant E, Safar V, Wallet F, Dhomps A, Brisou G, Bouafia F, Karlin L, Ghergus D, Golfier C, Lequeu H, Lazareth A, Vercasson M, Hospital-Gustem C, Schwiertz V, Choquet M, Sujobert P, Novelli S, Mialou V, Hequet O, Carras S, Fouillet L, Lebras L, Guillermin Y, Leyronnas C, Cavalieri D, Janier M, Ghesquières H, Salles G, Bachy E. Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells. Clin Nucl Med. 2021 Aug 1;46(8):627-634.
  99. Carnoy S, Beaumont JL, Kanouni T, Parquet N, Beauvais D, Hequet O, Kanold J, Ballot C, Mialou V, Reppel L, Damaj G, Yakoub-Agha I, Chabannon C. [How to perform leukapheresis for procurement of the staring material used for commercial CAR T-cell manufacturing: A consensus from experts convened by the SFGM-TC]. Bull Cancer. 2021. 108(3):295-303.
  100. Hadjadj J, Castro CN, Tusseau M, Stolzenberg MC, Mazerolles F, Aladjidi N, Armstrong M, Ashrafian H, Cutcutache I, Ebetsberger-Dachs G, Elliott KS, Durieu I, Fabien N, Fusaro M, Heeg M, Schmitt Y, Bras M, Knight JC, Lega JC, Lesca G, Mathieu AL, Moreews M, Moreira B, Nosbaum A, Page M, Picard C, Ronan Leahy T, Rouvet I, Ryan E, Sanlaville D, Schwarz K, Skelton A, Viallard JF, Viel S, Villard M, Callebaut I, Picard C, Walzer T, Ehl S, Fischer A, Neven B, Belot A, Rieux-Laucat F. Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nat Commun. 2020. 11(1):5341.
  101. Riis PT, Saunte DM, Sigsgaard V, Villani AP, Guillem P, Pascual JC, Kappe NN, Vanlaerhoven AMJD, van der Zee HH, Prens EP, El-Domyati M, Abdel-Wahab H, Moftah N, Abdelghani R, Agut-Busquet E, Romaní J, Hlela C, van den Worm L, Bettoli V, Calamo G, Gürer MA, Beksaç B, Matusiak L, Glowaczewska A, Szepietowski JC, Emtestam L, Lapins J, Kottb HR, Fatani M, Weibel L, Theiler M, Delage-Toriel M, Lam TTH, Nassif A, Becherel PA, Dolenc-Voljc M, Doss N, Bouazzi D, Benhadou F, Del Marmol V, Jemec GBE. Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients. Arch Dermatol Res. 2020. 312(10):715-724.
  102. Benhadou F, Villani AP, Guillem P. Hidradenitis Suppurativa and Bipolar Disorders: A Role for Lithium Therapy? Dermatology. 2020. 236(4):305-306.
  103. Benhadou F, Villani AP, Guillem P. Which Factors Determine Affected Sites in Hidradenitis Suppurativa? Dermatology. 2020. 236(1):15-20.
  104. Prouteau C, Dinulescu M, Oger E, Pruvost-Balland C, Buche S, Cogrel O, Delage M, Maruani A, Nicol I, Sbidian E, Villani AP, Viguier M, Chastagner M, Grodner C, Kaoutar J, Laurent C, Leducq S, Dupuy A, Droitcourt C; Groupe thématique HS-France de la Société Française de Dermatologie. Concordance of severity scores for photographic assessment of hidradenitis suppurativa. Br J Dermatol. 2020. 182(2):515-516.
  105. Karabajakian A, Garrivier T, Crozes C, Gadot N, Blay JY, Bérard F, Céruse P, Zrounba P, Saintigny P, Mastier C, Fayette J. Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma. Oncotarget. 2020. 11(18):1618-1628.
  106. Mangin MA, Kanitakis J, Jullien D, Lesort C. Dermpath & Clinic: Lichen planus pemphigoides. Eur J Dermatol. 2020. 30(2):211-213.
  107. Carlet C, Bichard D, Richard MA, Mahé E, Saillard C, Brenaut E, Dupuy A, Misery L, Villani A, Jullien D, Puzenat E, Nardin C, Aubin F, Groupe de Recherche Sur le Psoriasis de la Société Française de Dermatologie. Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective Study. Dermatol Res Pract. 2020. 2020:2042636.
  108. Néel A, Artifoni M, Fontenoy AM, Tessoulin B, Lorillon G, Cohen-Aubart F, Haroche J, Genereau T, de Menthon M, Guillevin L, Maillard H, Kahn JE, Hermine O, Araujo C, Dromer C, Jullien D, Hamidou M, Donadieu J, Tazi A. Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review. Br J Haematol. 2020. 189(5):869-878.
  109. Mignard C, Maho-Vaillant M, Golinski ML, Balayé P, Prost-Squarcioni C, Houivet E, Calbo SB, Labeille B, Picard-Dahan C, Konstantinou MP, Chaby G, Richard MA, Bouaziz JD, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Joly P, Hébert V; French Study Group on Autoimmune Bullous Skin Diseases. Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA Dermatol. 2020. 156(5):545-552.
  110. Thorel D, Ingen-Housz-Oro S, Royer G, Delcampe A, Bellon N, Bodemer C, Welfringer-Morin A, Bremond-Gignac D, Robert MP, Tauber M, Malecaze F, Dereure O, Daien V, Colin A, Bernier C, Couret C, Vabres B, Tetart F, Milpied B, Cornut T, Ben Said B, Burillon C, Cordel N, Beral L, de Prost N, Wolkenstein P, Muraine M, Gueudry J. Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus agreement. Orphanet J Rare Dis. 2020. 15(1):259.
  111. Combemale L, Ben Saïd B, Dupire G. Generalized bullous fixed drug eruption: Trazodone as a new culprit. Contact Dermatitis. 2020 Mar;82(3):192-193.
  112. Sesques P, Ferrant E, Safar V, Wallet F, Tordo J, Dhomps A, Karlin L, Brisou G, Vercasson M, Hospital-Gustem C, Schwiertz V, Ranchon F, Rioufol C, Choquet M, Sujobert P, Ghergus D, Bouafia F, Golfier C, Lequeu H, Lazareth A, Novelli S, Devic P, Traverse Glehen A, Viel S, Venet F, Mialou V, Hequet O, Chauchet A, Arkam Y, Nicolas-Virelizier E, Peyrade F, Cavalieri D, Ader F, Ghesquières H, Salles G, Bachy E. Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center. Am J Hematol. 2020. 95(11):1324-1333.
  113. Deschamps T, Bouschon P, Villani AP, Kanitakis J. Lipschütz ulcers with unusual localization in an adult woman. Eur J Dermatol. 2019. 29(3):348-349.
  114. Lesort C, Villani AP, Giai J, Becherel PA, Delaunay J, Fattouh K, Ducroux E, Jullien D, Guillem P. High prevalence of cannabis use among patients with hidradenitis suppurativa: results from the VERADDICT survey. Br J Dermatol. 2019. 181(4):839-841.
  115. Barbarin C, Hosteing S, Nosbaum A, Allouchery M, Celerier P. Early onset of alopecia areata after dupilumab introduction in a patient with atopic dermatitis. Eur J Dermatol. 2019. 29(5):542-543.
  116. Crepy MN, Nosbaum A, Bensefa-Colas L. Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema. Contact Dermatitis. 2019 Mar 9.
  117. Cloitre A, Duval X, Tubiana S, Giraud P, Veyrac G, Nosbaum A, Gouraud A, Mahé J, Lesclous P. Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France. Med Oral Patol Oral Cir Bucal. 2019 Apr 23.
  118. Faiz S, Giovannelli J, Podevin C, Jachiet M, Bouaziz JD, Reguiai Z, Nosbaum A, Lasek A, Ferrier le Bouedec MC, Du Thanh A, Raison-Peyron N, Tetart F, Duval-Modeste AB, Misery L, Aubin F, Dompmartin A, Morice C, Droitcourt C, Soria A, Arnault JP, Delaunay J, Mahe E, Richard MA, Schoeffler A, Lacour JP, Begon E, Walter-Lepage A, Dillies AS, Rappelle-Duruy S, Barete S, Bellon N, Beneton N, Valois A, Barbarot S, Seneschal J, Staumont-Salle D. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort. J Am Acad Dermatol. 2019 Feb 27.
  119. Droitcourt C, Barbarot S, Maruani A, Darrieux L, Misery L, Brenaut E, Adamski H, Chabbert C, Vermersch A, Weiborn M, Seneschal J, Taïeb A, Plantin P, Maillard H, Phan A, Skowron F, Viguier M, Staumont-Salle D, Nosbaum A, Soria A, Barbaud A, Oger E, Dupuy A; Groupe de Recherche sur l’Eczéma Atopique de la Société Française de Dermatologie (GREAT). A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis: study protocol for a multicentre, randomized, crossover, pragmatic trial - the PRADA trial. Trials. 2019 Mar 25;20(1):184.
  120. Lesort C, Villani AP, Giai J, Becherel PA, Delaunay J, Fattouh K, Ducroux E, Jullien D, Guillem P. High prevalence of cannabis use among patients with hidradenitis suppurativa: results from the VERADDICT survey. Br J Dermatol. 2019  Mar 28.
  121. Aussy A, Fréret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Fabienne J, Joly P, Isabelle M, Meyer A, Sibilia J, Bader-Meunier B, Hachulla E, Hamidou M, Huë S, Charuel JL, Fabien N, Viailly PJ, Allenbach Y, Benveniste O, Cordel N, Boyer O; OncoMyositis study group. The IgG2 isotype of anti-transcription intermediary factor 1-gamma autoantibodies is a biomarker of mortality in adult dermatomyositis. Arthritis Rheumatol. 2019 Mar 21.
  122. Siebert M, Alyami M, Mercier F, Gallice C, Villeneuve L, Bérard F, Glehen O, Bakrin N, Kepenekian V. Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report. Cancer Chemother Pharmacol. 2019. 83(3):425-430.
  123. Cornillier H, Giraudeau B, Samimi M, Munck S, Hacard F, Jonville-Bera AP, Jegou MH, d'Acremont G, Pham BN, Chosidow O, Maruani A. Effect of Diet in Chronic Spontaneous Urticaria: A Systematic Review. Acta Derm Venereol. 2019 Feb 1;99(2):127-132.
  124. Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E,  Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA,Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowron F, Paul C, Livideanu CB,Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology. Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.  J Invest Dermatol. 2019 Jan;139(1):31-37.
  125. Amatore F, Villani AP, Tauber M, Guillot B, Viguier M; Groupe de recherche sur le psoriasis de la Société française de dermatologie. [French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults]. Ann Dermatol Venereol. 2019. 146(6-7):429-439.
  126. Le Borgne De Lavillandre J, Lesort C, Martin C, Villani AP, Kanitakis J. Dermpath & Clinic: Exogenous ochronosis. Eur J Dermatol. 2019. 29(2):239-240.
  127. Amatore F, Villani AP, Tauber M, Viguier M, Guillot B; Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie). French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults. J Eur Acad Dermatol Venereol. 2019. 33(3):464-483.
  128. Guicciardi F, Atzori L, Marzano AV, Tavecchio S, Girolomoni G, Colato C, Villani AP, Kanitakis J, Mitteldorf C, Satta R, Cribier B, Gusdorf L, Rossi MT, Calzavara-Pinton P, Bielsa I, Fernandez-Figueras MT, Kempf W, Filosa G, Pilloni L, Rongioletti F. Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study. J Am Acad Dermatol. 2019. 81(2):403-411.
  129. Javaud N, Soria A, Maignan M, Martin L, Descamps V, Fain O, Bouillet L, Berard F, Tazarourte K, Roy PM, Fontaine JP, Bagot M, Khellaf M, Goulet H, Lapostolle F, Casalino E, Doutre MS, Gil-Jardine C, Caux F, Chosidow O, Pateron D, Vicaut E, Adnet F. Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial. BMJ Open. 2019. 9(8):e027431.
  130. Kanitakis J, Gouillon L, Jullien D, Ducroux E. Multiple acantholytic dyskeratotic acanthomas in a liver-transplant recipient. Dermatol Online J. 2019. 25(4):13030/qt24v5t78z.
  131. Aussy A, Fréret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Jouen F, Joly P, Marie I, Meyer A, Sibilia J, Bader-Meunier B, Hachulla E, Hamidou M, Huë S, Charuel JL, Fabien N, Viailly PJ, Allenbach Y, Benveniste O, Cordel N, Boyer O; OncoMyositis Study Group. The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis. Arthritis Rheumatol. 2019. 71(8):1360-1370.
  132. Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP, Egeberg A. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019. 80(1):251-265.e19.